ES2194904T3 - Agente carotenoide para inhibir la conversion de celulas epiteliales en tumores. - Google Patents

Agente carotenoide para inhibir la conversion de celulas epiteliales en tumores.

Info

Publication number
ES2194904T3
ES2194904T3 ES95914247T ES95914247T ES2194904T3 ES 2194904 T3 ES2194904 T3 ES 2194904T3 ES 95914247 T ES95914247 T ES 95914247T ES 95914247 T ES95914247 T ES 95914247T ES 2194904 T3 ES2194904 T3 ES 2194904T3
Authority
ES
Spain
Prior art keywords
conversion
epithelial cells
tumors
inhibit
carotenoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95914247T
Other languages
English (en)
Inventor
Lance Elliott Schlipalius
Julie A Buckmeier
Frank L Meyskens Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognis Australia Pty Ltd
Original Assignee
Cognis Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis Australia Pty Ltd filed Critical Cognis Australia Pty Ltd
Application granted granted Critical
Publication of ES2194904T3 publication Critical patent/ES2194904T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

AGENTE CAROTENOIDE QUE INHIBE LA CONVERSION DE CELULAS EPITELIALES EN TUMORES Y QUE INCLUYE UNA CANTIDAD EFECTIVA DEL COMPONENTE CAROTENOIDE INSOLUBLE AL AGUA EN UN MEDIO PORTADOR ADECUADO NO TOXICO.
ES95914247T 1994-04-08 1995-04-10 Agente carotenoide para inhibir la conversion de celulas epiteliales en tumores. Expired - Lifetime ES2194904T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM4931A AUPM493194A0 (en) 1994-04-08 1994-04-08 Therapeutic agent for inhibiting the conversion of epithelial cells to tumours

Publications (1)

Publication Number Publication Date
ES2194904T3 true ES2194904T3 (es) 2003-12-01

Family

ID=3779510

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95914247T Expired - Lifetime ES2194904T3 (es) 1994-04-08 1995-04-10 Agente carotenoide para inhibir la conversion de celulas epiteliales en tumores.

Country Status (8)

Country Link
EP (1) EP0754035B1 (es)
JP (1) JP3795075B2 (es)
AT (1) ATE234612T1 (es)
AU (1) AUPM493194A0 (es)
CA (1) CA2187367A1 (es)
DE (1) DE69529980T2 (es)
ES (1) ES2194904T3 (es)
WO (1) WO1995027483A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU752468B2 (en) 1997-04-04 2002-09-19 Phyllis E. Bowen Lutein esters having high bioavailability
US6759436B2 (en) 2002-02-01 2004-07-06 Micelle Products, Inc. Clear micellized formulations of β-carotene and method of treating leukoplakia
US6890961B2 (en) * 2002-02-01 2005-05-10 Micelle Products, Inc. Clear micellized formulations of β-carotene and method of treating leukoplakia
US7351424B2 (en) 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509587A (en) * 1975-08-19 1978-05-04 Ajinomoto Kk Anti-tumour composition
US4680314A (en) * 1985-08-30 1987-07-14 Microbio Resources, Inc. Process for producing a naturally-derived carotene/oil composition by direct extraction from algae
AU4058689A (en) * 1988-06-24 1990-01-12 Stephen Herman Ozonides of terpenes and their medical uses
FR2664164A1 (fr) * 1990-07-04 1992-01-10 Texinfine Patrinove Composition dermatologique ou cosmetique.
JPH04120019A (ja) * 1990-09-08 1992-04-21 Takao Matsuno 抗腫瘍剤
JPH05124958A (ja) * 1991-09-19 1993-05-21 Yukio Date 過酸化脂質低下作用を有する組成物
US5286474A (en) * 1992-10-22 1994-02-15 Arizona Board Of Regents, A Body Corporate, Acting For And On Behalf The Arizona State University Use of carotenoporphyrins as tumor localizing agents for diagnosis
ES2178651T3 (es) * 1993-03-22 2003-01-01 Cognis Australia Pty Ltd Compuestos carotenoides terapeuticos deispersables en agua.
ES2149264T3 (es) * 1993-03-22 2000-11-01 Cognis Australia Pty Ltd Agente terapeutico para el tratamiento de melanomas.

Also Published As

Publication number Publication date
JP3795075B2 (ja) 2006-07-12
EP0754035B1 (en) 2003-03-19
ATE234612T1 (de) 2003-04-15
AUPM493194A0 (en) 1994-05-05
DE69529980T2 (de) 2004-02-19
EP0754035A4 (en) 1998-07-08
EP0754035A1 (en) 1997-01-22
DE69529980D1 (de) 2003-04-24
WO1995027483A1 (en) 1995-10-19
JPH09511508A (ja) 1997-11-18
CA2187367A1 (en) 1995-10-19

Similar Documents

Publication Publication Date Title
ES2178651T3 (es) Compuestos carotenoides terapeuticos deispersables en agua.
MX9704778A (es) Formulaciones para reducir irritaciones de la piel y uso de las mismas.
BG104056A (en) Triazole compounds and their use as dopamine-d3-ligands
IT8221346A0 (it) Composti per stabilizzare i polimeri.
ES8100457A1 (es) Perfeccionamientos en los dispositivos de borde iluminado
ES552627A0 (es) Procedimiento para la preparacion de carbamatos de fenilo
ES2179337T3 (es) Disulfuros de triazolilo.
DE69835773D1 (de) Wasserverträgliche energie-härtbare zusammensetzungen, die maleimidderivate enthalten
ES2194904T3 (es) Agente carotenoide para inhibir la conversion de celulas epiteliales en tumores.
GB2324091A (en) Metalloproteinase inhibitors
ES2185196T3 (es) Un procedimiento para la preparacion de tetraazamacrociclos.
ES8405779A1 (es) Un procedimiento para preparar derivados de 1-fenoxi-3-(4-fenilpiperazino)-2-propanol.
IT7822095A0 (it) Procedimento per fabbricare perborato di sodio monoidrato, eprodotto ottenuto secondo il procedimento.
DE3481167D1 (de) Sebosuppressive kosmetische mittel, enthaltend alkoxyaryl-alkanole.
JPS53113025A (en) Proliferation inhibitor for microorganisms
JPS5315344A (en) Preparation of 5-cyclohexadecene-1-one
JPS52117435A (en) Immuno-carcinostatic agent
DK80292A (da) Hydroxylgruppefrie, o-alklerede glycosylfluorider
RU2076517C1 (ru) Пищевой краситель
ATE26523T1 (de) Langwierig freisetzende, mikrobiozide gegenstaende verhaeltnismaessig hohe wasserloesliche mikrobiozide enthaltend.
JPS5432887A (en) Water-soluble anti-rust cutting oil
ES493675A0 (es) Procedimiento para anadir cal, en calidad de agente floculante, a agua residual y similares.
GT198276660A (es) Derivados de tetrahidronaftaleno e indano
BE896630A (fr) Compositions multicellulaires, utilisables notamment comme materiaux de flottabilite.
ES508746A0 (es) "procedimiento, con su instalacion, para envasar cloruro de hidrogeno".